{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:13:51Z","timestamp":1760044431031},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.thromres.2018.03.006","type":"journal-article","created":{"date-parts":[[2018,3,10]],"date-time":"2018-03-10T19:30:14Z","timestamp":1520710214000},"page":"24-32","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms"],"prefix":"10.1016","volume":"165","author":[{"given":"Boris","family":"Aleksovski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"Neceva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktorija","family":"Vujovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nensi","family":"Manusheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir","family":"Rendevski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Novotni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Filipce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastazija","family":"Spasovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aspazija","family":"Sofijanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasko","family":"Aleksovski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Icko","family":"Gjorgoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2018.03.006_bb0005","series-title":"The World Health Report 2001 \u2013 Mental Health: New Understanding, New Hope","author":"WHO","year":"2001"},{"key":"10.1016\/j.thromres.2018.03.006_bb0010","series-title":"The Global Burden of Disease: 2004 Update","author":"WHO","year":"2008"},{"key":"10.1016\/j.thromres.2018.03.006_bb0015","series-title":"Depression: A Global Crisis, World Mental Health Day, October 10, 2012","author":"WHO","year":"2012"},{"key":"10.1016\/j.thromres.2018.03.006_bb0020","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00001648-199307000-00003","article-title":"Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of US adults","volume":"4","author":"Anda","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/j.thromres.2018.03.006_bb0025","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1161\/01.CIR.93.11.1976","article-title":"Symptoms of depression, acute myocardial infarction, and total mortality in a community sample","volume":"93","author":"Barefoot","year":"1996","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.006_bb0030","doi-asserted-by":"crossref","DOI":"10.29046\/JJP.012.1.001","article-title":"The serotonin theory of depression","volume":"12","author":"Kerr","year":"1994","journal-title":"Jefferson J. Psychiatry"},{"issue":"2","key":"10.1016\/j.thromres.2018.03.006_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/clinchem\/40.2.279","article-title":"Catecholamines in depression: an update","volume":"40","author":"Potter","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.thromres.2018.03.006_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archfami.7.1.78","article-title":"Selective serotonin reuptake inhibitors: infrequent medical adverse effects","volume":"7","author":"Goldberg","year":"1998","journal-title":"Arch. Fam. Med."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.006_bb0045","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/appi.ajp.157.6.1006","article-title":"Platelet activation in depression and effects of sertraline treatment: an open-label study","volume":"157","author":"Markovitz","year":"2000","journal-title":"Am. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.thromres.2018.03.006_bb0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.thromres.2018.03.006_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.amjmed.2005.03.044","article-title":"Selective serotonin reuptake inhibitors and increased bleeding risk: are we missing something?","volume":"119","author":"Serebruany","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2018.03.006_bb0060","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4088\/JCP.09r05786blu","article-title":"Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms","volume":"71","author":"Andrade","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.thromres.2018.03.006_bb0065","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0033-3182(96)71592-X","article-title":"Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors","volume":"37","author":"Skop","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1016\/j.thromres.2018.03.006_bb0070","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.thromres.2018.03.006_bb0075","first-page":"497","article-title":"Platelet secretory granules and associated proteins","volume":"68","author":"White","year":"1993","journal-title":"Lab. Investig."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.006_bb0080","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1067\/mcp.2000.110456","article-title":"Paroxetine decreases platelet serotonin storage and platelet function in human beings","volume":"68","author":"Hergovich","year":"2000","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.thromres.2018.03.006_bb0085","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cvr\/cvp205","article-title":"Serotonin enhances platelet procoagulant properties and their activation induced during platelet tissue factor uptake","volume":"84","author":"Lopez-Vilchez","year":"2009","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.006_bb0090","first-page":"477","article-title":"Alpha adrenergic receptor function in schizophrenia, affective disorders and some neurological diseases","volume":"4","author":"Kafka","year":"1980","journal-title":"Commun. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.006_bb0095","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/clpt.2009.121","article-title":"Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease","volume":"86","author":"Pizzi","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2018.03.006_bb0100","doi-asserted-by":"crossref","DOI":"10.1080\/13651501.2017.1411516","article-title":"Evaluation of peripheral serotonin content and \u03b12-adrenergic receptor function as potential markers for life-long recurrent depressive disorder by using methodological improvements","author":"Aleksovski","year":"2017","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"1","key":"10.1016\/j.thromres.2018.03.006_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2011.08793.x","article-title":"Guidelines for the laboratory investigation of heritable disorders of platelet function","volume":"155","author":"Harrison","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2018.03.006_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000205234","article-title":"Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens","volume":"17","author":"Clauss","year":"1957","journal-title":"Acta Haematol."},{"key":"10.1016\/j.thromres.2018.03.006_bb0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/194927b0","article-title":"Aggregation of blood platelets by adenosine diphosphate and its reversal","volume":"194","author":"Born","year":"1962","journal-title":"Nature"},{"key":"10.1016\/j.thromres.2018.03.006_bb0120","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1537-2995.1999.39070724.x","article-title":"Effects of prestorage white cell reduction on platelet aggregate formation and the activation state of platelets and plasma enzyme systems","volume":"39","author":"Devine","year":"1999","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.thromres.2018.03.006_bb0125","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1538-7836.2008.03196.x","article-title":"Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism","volume":"6","author":"Abdelmalik","year":"2008","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.006_bb0130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.trsl.2007.10.004","article-title":"Selective serotonin reuptake inhibitors: measurement of effect on platelet function","volume":"151","author":"McCloskey","year":"2008","journal-title":"Transl. Res."},{"issue":"1\u20132","key":"10.1016\/j.thromres.2018.03.006_bb0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jad.2011.08.013","article-title":"Decreased serotonin content and reduced agonist-induced aggregation in platelets of patients chronically medicated with SSRI drugs","volume":"136","author":"Bismuth-Evenzal","year":"2012","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.thromres.2018.03.006_bb0140","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.thromres.2010.09.017","article-title":"A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation","volume":"126","author":"Tseng","year":"2010","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.006_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.thromres.2013.02.007","article-title":"Selective serotonin reuptake inhibitors reduce P2Y12 receptor-mediated amplification of platelet aggregation","volume":"131","author":"Tseng","year":"2013","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.006_bb0150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-0327(91)90028-Q","article-title":"Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients","volume":"23","author":"M\u00fcck-Seler","year":"1991","journal-title":"J. Affect. Disord."},{"issue":"7\u20138","key":"10.1016\/j.thromres.2018.03.006_bb0155","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0278-5846(02)00259-2","article-title":"The effects of paroxetine and tianeptine on peripheral biochemical markers in major depression","volume":"26","author":"M\u00fcck-Seler","year":"2002","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.006_bb0160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0278-5846(03)00105-2","article-title":"Long-term sertraline treatment and peripheral biochemical markers in female depressed patients","volume":"27","author":"Pivac","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.006_bb0165","first-page":"23","article-title":"Platelet serotonin levels support depression scores for women with postpartum depression","volume":"32","author":"Maurer-Spurej","year":"2007","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.thromres.2018.03.006_bb0170","first-page":"149","article-title":"Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity","volume":"32","author":"Celada","year":"1990","journal-title":"J. Neural Transm. Suppl."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1097\/00004714-199210000-00003","article-title":"Monoamine oxidase inhibitors phenelzine and brofaromine increase plasma serotonin and decrease 5-hydroxyindoleacetic acid in patients with major depression: relationship to clinical improvement","volume":"12","author":"Celada","year":"1992","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.thromres.2018.03.006_bb0180","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s00216-011-5583-1","article-title":"Evaluation of a novel ELISA for serotonin: urinary serotonin as a potential biomarker for depression","volume":"402","author":"Nichkova","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"issue":"5","key":"10.1016\/j.thromres.2018.03.006_bb0185","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0361-9230(01)00623-2","article-title":"Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists","volume":"56","author":"Gray","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.thromres.2018.03.006_bb0190","series-title":"Neuropsychopharmacology: Proceedings of the XVIth C.I.N.P. Congress, Munich, August 15\u201319","first-page":"163","article-title":"Changes in platelet serotonergic and adrenergic function in patients with depression, panic attack, and mania","author":"Leonard","year":"1990"},{"issue":"8851","key":"10.1016\/j.thromres.2018.03.006_bb0195","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/0140-6736(93)91121-2","article-title":"Platelet alpha-2 adrenoceptor-mediated primary aggregation and adenylate cyclase inhibition in depressed patients","volume":"341","author":"Karege","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2018.03.006_bb0200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1176\/ajp.139.10.1315","article-title":"High plasma norepinephrine levels in patients with major affective disorder","volume":"139","author":"Lake","year":"1982","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.thromres.2018.03.006_bb0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/archpsyc.1985.01790350055010","article-title":"Plasma norepinephrine level in affective disorders: relationship to melancholia","volume":"42","author":"Roy","year":"1985","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.thromres.2018.03.006_bb0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/YCO.0b013e328315a561","article-title":"Inflammatory markers in depression","volume":"22","author":"Dinan","year":"2009","journal-title":"Current Opinion in Psychiatry"},{"issue":"5","key":"10.1016\/j.thromres.2018.03.006_bb0215","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2141.2004.05357.x","article-title":"Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia","volume":"128","author":"Kaito","year":"2005","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2018.03.006_bb0220","first-page":"28","article-title":"Platelet distribution width: a simple, practical and specific marker of activation of coagulation","volume":"14","author":"Vagdatli","year":"2010","journal-title":"Hippokratia"},{"issue":"2","key":"10.1016\/j.thromres.2018.03.006_bb0225","doi-asserted-by":"crossref","first-page":"178","DOI":"10.11613\/BM.2016.020","article-title":"The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review","volume":"26","author":"Budak","year":"2016","journal-title":"Biochem. Med. (Zagreb)"},{"key":"10.1016\/j.thromres.2018.03.006_bb0230","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/JCP.0b013e3181abdfd7","article-title":"Mean platelet volume in patients with major depression: effect of escitalopram treatment","volume":"29","author":"Ataoglu","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.thromres.2018.03.006_bb0235","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jpsychires.2011.11.016","article-title":"Association of mean platelet volume with DSM-IV major depression in a large community-based population: the MELEN study","volume":"46","author":"Canan","year":"2012","journal-title":"J. Psychiatr. Res."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818302755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T01:38:34Z","timestamp":1603935514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818302755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":47,"alternative-id":["S0049384818302755"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SSRI-reduced platelet reactivity in non-responding patients with life-long Recurrent Depressive Disorder: Detection and involved mechanisms","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}